August 2022

NEUROSCIENCES

CLINICAL GUIDELINES: ACUTE, LONG-TERM NEUROLOGIC MANIFESTATIONS OF COVID-19

Between the beginning of the COVID-19 pandemic and May 2022, more than 527 million cases of SARS-CoV-2 have been confirmed. COVID-19 represents an ongoing challenge to the field of neurology, as neurologic complications of the disease are leading to an increase in demand for both acute and long-term neurologic evaluation and management. Three experts from Northwestern Medicine Neurology — Igor J. Koralnik, MD, Eric M. Liotta, MD, and Edith L. Graham, MD — have been investigating the pathogenic mechanisms of acute and long-term COVID-19, as they may inform clinical evaluation and management. They discuss diagnostic and treatment guidelines,  "Therapeutic Approaches to the Neurologic Manifestations of COVID-19," published in Neurotherapeutics in July 2022.
Edith L. Graham, MD, is an assistant professor of Neurology in the Division of Multiple Sclerosis and Neuroimmunology at Northwestern Medicine.
Igor J. Koralnik, MD, is the Archibald Church Professor of Neurology and chief of Neuro-infectious Diseases and Global Neurology in the Department of Neurology. He also oversees the Neuro COVID-19 Clinic at Northwestern Medicine.
Eric M. Liotta, MD, MS, is an associate professor of Surgery and of Neurology in the Division of Neurocritical Care at Northwestern Medicine.

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. 

You May Also Like